107.521 articles found

Identification of electromyographic patterns of bradykinesia in patients with Parkinson's disease

Kozulin N, Migulina A, Mokrushin D, Soghoyan G, Artemenko A, Biktimirov A.

Heliyon · 2024-10-01

Effects of positive psychology intervention based on the PERMA model on psychological status and quality of life in patients with Parkinson's disease

Yao Y, Wang CJ, Yin SY, Xu Gz, Cheng YF, Huang QQ, Jin Y.

Heliyon · 2024-10-01

The effect of deep brain stimulation on cortico-subcortical networks in Parkinson's disease patients with freezing of gait: Exhaustive exploration of a basic model.

Popova M, Messé A, Gulberti A, Gerloff C, Pötter-Nerger M, Hilgetag CC.

Netw Neurosci · 2024-10-01

DOI: 10.1162/netn_a_00376PMID: 39355431

SEND-PD in Parkinsonian Syndromes: Results of a Monocentric Cross-Sectional Study.

Veith Sanches L, Greten S, Doll-Lee J, Rogozinski SM, Heine J, Krey L, Ulaganathan S, Jensen I, Höllerhage M, Sani SS, Höglinger GU, Wegner F, Klietz M.

Neuropsychiatr Dis Treat · 2024-10-01

DOI: 10.2147/ndt.s474584PMID: 39372876

Coumarin-chalcone derivatives as dual NLRP1 and NLRP3 inflammasome inhibitors targeting oxidative stress and inflammation in neurotoxin-induced HMC3 and BE(2)-M17 cell models of Parkinson's disease.

Lin TH, Chiu YJ, Lin CH, Chen YR, Lin W, Wu YR, Chang KH, Chen CM, Lee-Chen GJ.

Front Aging Neurosci · 2024-10-01

DOI: 10.3389/fnagi.2024.1437138PMID: 39411284

A Novel Kinematic Gait Parameter-Based Vibrotactile Cue for Freezing of Gait Mitigation Among Parkinson's Patients: A Pilot Study.

Khatavkar R, Tiwari A, Bhat P, Srivastava AK, Kumaran SS, Joshi D.

IEEE Trans Haptics · 2024-10-01

DOI: 10.1109/toh.2024.3378917PMID: 38526896

Co-Occurrence of Apathy and Impulse Control Disorders in Parkinson Disease: Variation across Multiple Measures.

Scott BM, Eisinger RS, Mara R, Rana AN, Thompson S, Okun MS, Gunduz A, Bowers D.

Arch Clin Neuropsychol · 2024-10-01

DOI: 10.1093/arclin/acae036PMID: 38704737

The immune system in Parkinson's disease: what we know so far.

Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, Aktas B, Pita C, Ciglar L, Garraux G, Williams-Gray C, Pacheco R, Romero-Ramos M.

Brain · 2024-10-01

DOI: 10.1093/brain/awae177PMID: 38833182

Cholinergic deficiency in Parkinson's disease patients with visual hallucinations.

d'Angremont E, van der Zee S, Slingerland S, Slomp AC, de Vries EFJ, van Laar T, Sommer IE.

Brain · 2024-10-01

DOI: 10.1093/brain/awae186PMID: 38864492

Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.

Brendel M, Guedj E, Yakushev I, Morbelli S, Höglinger GU, Tolboom N, Verger A, Albert NL, Cecchin D, Fernandez PA, Fraioli F, Traub-Weidinger T, Van Weehaeghe D, Barthel H.

Eur J Nucl Med Mol Imaging · 2024-10-01

DOI: 10.1007/s00259-024-06803-wPMID: 38907856

Putaminal dopamine modulates movement motivation in Parkinson's disease.

Banwinkler M, Dzialas V, Rigoux L, Asendorf AL, Theis H, Giehl K, Tittgemeyer M, Hoenig MC, van Eimeren T.

Brain · 2024-10-01

DOI: 10.1093/brain/awae214PMID: 38941444

Dopamine and deep brain stimulation accelerate the neural dynamics of volitional action in Parkinson's disease.

Köhler RM, Binns TS, Merk T, Zhu G, Yin Z, Zhao B, Chikermane M, Vanhoecke J, Busch JL, Habets JGV, Faust K, Schneider GH, Cavallo A, Haufe S, Zhang J, Kühn AA, Haynes JD, Neumann WJ.

Brain · 2024-10-01

DOI: 10.1093/brain/awae219PMID: 38954651